Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Submits Application to FDA for Respiratory Virus Assay

NEW YORK (GenomeWeb News) – Nanosphere today said that it has filed a 510(k) application to the US Food and Drug Administration for marketing clearance of its Verigene SP Respiratory Virus Assay.

The assay detects influenza and respiratory syncytial virus and runs on the firm's Verigene SP system, an automated sample-to-result molecular diagnostic instrument. The Verigene SP is a newer version of the firm's first-generation Verigene system.

"The market has strongly signaled its need for a flu test that provides greater sensitivity than currently available rapid tests, combined with optimized ease of use and turnaround time not found in either traditional culture methods or the currently available molecular tests," Nanosphere President and CEO William Moffitt said in a statement. "Our respiratory panel running on the Verigene SP directly addresses these market needs."

The firm also noted that it intends to submit additional FDA applications for each of its previously 510(k)-cleared assays — including a thrombophilia or hypercoagulation panel, a warfarin metabolism assay, and a cystic fibrosis panel — for use on the Verigene SP.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.